PubMed:8045270
Annnotations
bc5cdr-valid-experiment
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 27-36 | Chemical | denotes | adenosine |
| T3 | 91-98 | Chemical | denotes | KF17837 |
| T4 | 120-129 | Chemical | denotes | adenosine |
| T5 | 178-185 | Chemical | denotes | KF17837 |
| T6 | 243-253 | Disease | denotes | cataleptic |
| T7 | 320-329 | Chemical | denotes | adenosine |
| T8 | 352-361 | Chemical | denotes | CGS 21680 |
| T9 | 407-414 | Chemical | denotes | KF17837 |
| T10 | 432-441 | Disease | denotes | catalepsy |
| T11 | 453-464 | Chemical | denotes | haloperidol |
| T12 | 487-496 | Chemical | denotes | reserpine |
| T13 | 638-645 | Chemical | denotes | KF17837 |
| T14 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T15 | 760-766 | Chemical | denotes | L-DOPA |
| T16 | 788-799 | Chemical | denotes | benserazide |
| T17 | 848-855 | Chemical | denotes | KF17837 |
| T18 | 878-887 | Chemical | denotes | adenosine |
| T19 | 994-1003 | Chemical | denotes | adenosine |
| T20 | 1043-1050 | Chemical | denotes | KF17837 |
| T21 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-deepseek-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 91-98 | Chemical | denotes | KF17837 |
| T3 | 178-185 | Chemical | denotes | KF17837 |
| T4 | 352-361 | Chemical | denotes | CGS 21680 |
| T5 | 407-414 | Chemical | denotes | KF17837 |
| T6 | 453-464 | Chemical | denotes | haloperidol |
| T7 | 487-496 | Chemical | denotes | reserpine |
| T8 | 638-645 | Chemical | denotes | KF17837 |
| T9 | 760-767 | Chemical | denotes | L-DOPA; |
| T10 | 788-799 | Chemical | denotes | benserazide |
| T11 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-gemini-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 27-60 | Chemical | denotes | adenosine A2A receptor antagonist |
| T3 | 91-98 | Chemical | denotes | KF17837 |
| T4 | 120-153 | Chemical | denotes | adenosine A2A receptor antagonist |
| T5 | 178-185 | Chemical | denotes | KF17837 |
| T6 | 243-253 | Disease | denotes | cataleptic |
| T7 | 352-361 | Chemical | denotes | CGS 21680 |
| T8 | 407-414 | Chemical | denotes | KF17837 |
| T9 | 432-441 | Disease | denotes | catalepsy |
| T10 | 453-464 | Chemical | denotes | haloperidol |
| T11 | 487-496 | Chemical | denotes | reserpine |
| T12 | 638-645 | Chemical | denotes | KF17837 |
| T13 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T14 | 760-766 | Chemical | denotes | L-DOPA |
| T15 | 788-799 | Chemical | denotes | benserazide |
| T16 | 848-855 | Chemical | denotes | KF17837 |
| T17 | 878-911 | Chemical | denotes | adenosine A2A receptor antagonist |
| T18 | 994-1028 | Chemical | denotes | adenosine A2A receptor antagonists |
| T19 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 27-36 | Chemical | denotes | adenosine |
| T3 | 91-98 | Chemical | denotes | KF17837 |
| T4 | 120-129 | Chemical | denotes | adenosine |
| T5 | 178-185 | Chemical | denotes | KF17837 |
| T6 | 243-253 | Disease | denotes | cataleptic |
| T7 | 320-329 | Chemical | denotes | adenosine |
| T8 | 352-361 | Chemical | denotes | CGS 21680 |
| T9 | 407-414 | Chemical | denotes | KF17837 |
| T10 | 432-441 | Disease | denotes | catalepsy |
| T11 | 453-464 | Chemical | denotes | haloperidol |
| T12 | 487-496 | Chemical | denotes | reserpine |
| T13 | 638-645 | Chemical | denotes | KF17837 |
| T14 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T15 | 760-766 | Chemical | denotes | L-DOPA |
| T16 | 788-799 | Chemical | denotes | benserazide |
| T17 | 848-855 | Chemical | denotes | KF17837 |
| T18 | 878-887 | Chemical | denotes | adenosine |
| T19 | 994-1003 | Chemical | denotes | adenosine |
| T20 | 1043-1050 | Chemical | denotes | KF17837 |
| T21 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-gemini-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 27-36 | Chemical | denotes | adenosine |
| T3 | 66-80 | Disease | denotes | anticataleptic |
| T4 | 91-98 | Chemical | denotes | KF17837 |
| T5 | 120-129 | Chemical | denotes | adenosine |
| T6 | 178-185 | Chemical | denotes | KF17837 |
| T7 | 243-253 | Disease | denotes | cataleptic |
| T8 | 320-329 | Chemical | denotes | adenosine |
| T9 | 352-361 | Chemical | denotes | CGS 21680 |
| T10 | 407-414 | Chemical | denotes | KF17837 |
| T11 | 432-441 | Disease | denotes | catalepsy |
| T12 | 453-464 | Chemical | denotes | haloperidol |
| T13 | 487-496 | Chemical | denotes | reserpine |
| T14 | 519-533 | Disease | denotes | anticataleptic |
| T15 | 638-645 | Chemical | denotes | KF17837 |
| T16 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T17 | 760-766 | Chemical | denotes | L-DOPA |
| T18 | 788-799 | Chemical | denotes | benserazide |
| T19 | 878-887 | Chemical | denotes | adenosine |
| T20 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-gemini-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 27-60 | Chemical | denotes | adenosine A2A receptor antagonist |
| T3 | 91-98 | Chemical | denotes | KF17837 |
| T4 | 120-153 | Chemical | denotes | adenosine A2A receptor antagonist |
| T5 | 178-185 | Chemical | denotes | KF17837 |
| T6 | 320-350 | Chemical | denotes | adenosine A2A receptor agonist |
| T7 | 352-361 | Chemical | denotes | CGS 21680 |
| T8 | 407-414 | Chemical | denotes | KF17837 |
| T9 | 432-441 | Disease | denotes | catalepsy |
| T10 | 453-464 | Chemical | denotes | haloperidol |
| T11 | 487-496 | Chemical | denotes | reserpine |
| T12 | 638-645 | Chemical | denotes | KF17837 |
| T13 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T14 | 760-766 | Chemical | denotes | L-DOPA |
| T15 | 788-799 | Chemical | denotes | benserazide |
| T16 | 878-911 | Chemical | denotes | adenosine A2A receptor antagonist |
| T17 | 994-1028 | Chemical | denotes | adenosine A2A receptor antagonists |
| T18 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-gemini-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 27-36 | Chemical | denotes | adenosine |
| T3 | 70-80 | Disease | denotes | cataleptic |
| T4 | 91-98 | Chemical | denotes | KF17837 |
| T5 | 120-129 | Chemical | denotes | adenosine |
| T6 | 178-185 | Chemical | denotes | KF17837 |
| T7 | 243-253 | Disease | denotes | cataleptic |
| T8 | 320-329 | Chemical | denotes | adenosine |
| T9 | 352-361 | Chemical | denotes | CGS 21680 |
| T10 | 407-414 | Chemical | denotes | KF17837 |
| T11 | 432-441 | Disease | denotes | catalepsy |
| T12 | 453-464 | Chemical | denotes | haloperidol |
| T13 | 487-496 | Chemical | denotes | reserpine |
| T14 | 519-533 | Disease | denotes | anticataleptic |
| T15 | 638-645 | Chemical | denotes | KF17837 |
| T16 | 681-695 | Disease | denotes | anticataleptic |
| T17 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T18 | 760-766 | Chemical | denotes | L-DOPA |
| T19 | 788-799 | Chemical | denotes | benserazide |
| T20 | 848-855 | Chemical | denotes | KF17837 |
| T21 | 878-887 | Chemical | denotes | adenosine |
| T22 | 1043-1050 | Chemical | denotes | KF17837 |
| T23 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-gpt-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 91-98 | Chemical | denotes | KF17837 |
| T3 | 178-185 | Chemical | denotes | KF17837 |
| T4 | 243-253 | Disease | denotes | cataleptic |
| T5 | 352-361 | Chemical | denotes | CGS 21680 |
| T6 | 407-414 | Chemical | denotes | KF17837 |
| T7 | 432-441 | Disease | denotes | catalepsy |
| T8 | 453-464 | Chemical | denotes | haloperidol |
| T9 | 487-496 | Chemical | denotes | reserpine |
| T10 | 638-645 | Chemical | denotes | KF17837 |
| T11 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T12 | 760-766 | Chemical | denotes | L-DOPA |
| T13 | 788-799 | Chemical | denotes | benserazide |
| T14 | 848-855 | Chemical | denotes | KF17837 |
| T15 | 1043-1050 | Chemical | denotes | KF17837 |
| T16 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-gpt-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 91-98 | Chemical | denotes | KF17837 |
| T3 | 178-185 | Chemical | denotes | KF17837 |
| T4 | 352-361 | Chemical | denotes | CGS 21680 |
| T5 | 407-414 | Chemical | denotes | KF17837 |
| T6 | 432-441 | Disease | denotes | catalepsy |
| T7 | 453-464 | Chemical | denotes | haloperidol |
| T8 | 487-496 | Chemical | denotes | reserpine |
| T9 | 638-645 | Chemical | denotes | KF17837 |
| T10 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T11 | 760-766 | Chemical | denotes | L-DOPA |
| T12 | 788-799 | Chemical | denotes | benserazide |
| T13 | 848-855 | Chemical | denotes | KF17837 |
| T14 | 1043-1050 | Chemical | denotes | KF17837 |
| T15 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-gpt-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 91-98 | Chemical | denotes | KF17837 |
| T3 | 178-185 | Chemical | denotes | KF17837 |
| T4 | 243-253 | Disease | denotes | cataleptic |
| T5 | 352-361 | Chemical | denotes | CGS 21680 |
| T6 | 407-414 | Chemical | denotes | KF17837 |
| T7 | 432-441 | Disease | denotes | catalepsy |
| T8 | 453-464 | Chemical | denotes | haloperidol |
| T9 | 487-496 | Chemical | denotes | reserpine |
| T10 | 638-645 | Chemical | denotes | KF17837 |
| T11 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T12 | 760-766 | Chemical | denotes | L-DOPA |
| T13 | 788-799 | Chemical | denotes | benserazide |
| T14 | 848-855 | Chemical | denotes | KF17837 |
| T15 | 1043-1050 | Chemical | denotes | KF17837 |
| T16 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-gpt-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 91-98 | Chemical | denotes | KF17837 |
| T3 | 178-185 | Chemical | denotes | KF17837 |
| T4 | 243-263 | Disease | denotes | cataleptic responses |
| T5 | 352-361 | Chemical | denotes | CGS 21680 |
| T6 | 407-414 | Chemical | denotes | KF17837 |
| T7 | 432-441 | Disease | denotes | catalepsy |
| T8 | 453-464 | Chemical | denotes | haloperidol |
| T9 | 487-496 | Chemical | denotes | reserpine |
| T10 | 638-645 | Chemical | denotes | KF17837 |
| T11 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T12 | 760-766 | Chemical | denotes | L-DOPA |
| T13 | 788-799 | Chemical | denotes | benserazide |
| T14 | 848-855 | Chemical | denotes | KF17837 |
| T15 | 1043-1050 | Chemical | denotes | KF17837 |
| T16 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-deepseek-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 91-98 | Chemical | denotes | KF17837 |
| T3 | 352-361 | Chemical | denotes | CGS 21680 |
| T4 | 432-441 | Disease | denotes | catalepsy |
| T5 | 453-464 | Chemical | denotes | haloperidol |
| T6 | 487-496 | Chemical | denotes | reserpine |
| T7 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T8 | 760-766 | Chemical | denotes | L-DOPA |
| T9 | 788-799 | Chemical | denotes | benserazide |
| T10 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-gemini-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 27-36 | Chemical | denotes | adenosine |
| T3 | 66-80 | Disease | denotes | anticataleptic |
| T4 | 91-98 | Chemical | denotes | KF17837 |
| T5 | 120-129 | Chemical | denotes | adenosine |
| T6 | 178-185 | Chemical | denotes | KF17837 |
| T7 | 243-253 | Disease | denotes | cataleptic |
| T8 | 320-329 | Chemical | denotes | adenosine |
| T9 | 352-361 | Chemical | denotes | CGS 21680 |
| T10 | 407-414 | Chemical | denotes | KF17837 |
| T11 | 432-441 | Disease | denotes | catalepsy |
| T12 | 453-464 | Chemical | denotes | haloperidol |
| T13 | 487-496 | Chemical | denotes | reserpine |
| T14 | 519-533 | Disease | denotes | anticataleptic |
| T15 | 638-645 | Chemical | denotes | KF17837 |
| T16 | 681-695 | Disease | denotes | anticataleptic |
| T17 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T18 | 760-766 | Chemical | denotes | L-DOPA |
| T19 | 788-799 | Chemical | denotes | benserazide |
| T20 | 848-855 | Chemical | denotes | KF17837 |
| T21 | 878-887 | Chemical | denotes | adenosine |
| T22 | 994-1003 | Chemical | denotes | adenosine |
| T23 | 1043-1050 | Chemical | denotes | KF17837 |
| T24 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-gpt-r-m2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 91-98 | Chemical | denotes | KF17837 |
| T3 | 178-185 | Chemical | denotes | KF17837 |
| T4 | 243-253 | Disease | denotes | cataleptic |
| T5 | 352-361 | Chemical | denotes | CGS 21680 |
| T6 | 407-414 | Chemical | denotes | KF17837 |
| T7 | 432-441 | Disease | denotes | catalepsy |
| T8 | 453-464 | Chemical | denotes | haloperidol |
| T9 | 487-496 | Chemical | denotes | reserpine |
| T10 | 638-645 | Chemical | denotes | KF17837 |
| T11 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T12 | 760-766 | Chemical | denotes | L-DOPA |
| T13 | 788-799 | Chemical | denotes | benserazide |
| T14 | 848-855 | Chemical | denotes | KF17837 |
| T15 | 1043-1050 | Chemical | denotes | KF17837 |
| T16 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-deepseek-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 70-80 | Disease | denotes | cataleptic |
| T3 | 91-98 | Chemical | denotes | KF17837 |
| T4 | 178-185 | Chemical | denotes | KF17837 |
| T5 | 352-361 | Chemical | denotes | CGS 21680 |
| T6 | 407-414 | Chemical | denotes | KF17837 |
| T7 | 432-441 | Disease | denotes | catalepsy |
| T8 | 453-464 | Chemical | denotes | haloperidol |
| T9 | 487-496 | Chemical | denotes | reserpine |
| T10 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T11 | 760-766 | Chemical | denotes | L-DOPA |
| T12 | 788-799 | Chemical | denotes | benserazide |
| T13 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-deepseek-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 91-98 | Chemical | denotes | KF17837 |
| T3 | 178-185 | Chemical | denotes | KF17837 |
| T4 | 352-361 | Chemical | denotes | CGS 21680 |
| T5 | 407-414 | Chemical | denotes | KF17837 |
| T6 | 453-464 | Chemical | denotes | haloperidol |
| T7 | 487-496 | Chemical | denotes | reserpine |
| T8 | 638-645 | Chemical | denotes | KF17837 |
| T9 | 788-799 | Chemical | denotes | benserazide |
| T10 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-deepseek-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 91-98 | Chemical | denotes | KF17837 |
| T3 | 178-185 | Chemical | denotes | KF17837 |
| T4 | 243-253 | Disease | denotes | cataleptic |
| T5 | 352-361 | Chemical | denotes | CGS 21680 |
| T6 | 407-414 | Chemical | denotes | KF17837 |
| T7 | 432-441 | Disease | denotes | catalepsy |
| T8 | 453-464 | Chemical | denotes | haloperidol |
| T9 | 487-496 | Chemical | denotes | reserpine |
| T10 | 638-645 | Chemical | denotes | KF17837 |
| T11 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T12 | 760-766 | Chemical | denotes | L-DOPA |
| T13 | 788-799 | Chemical | denotes | benserazide |
| T14 | 848-855 | Chemical | denotes | KF17837 |
| T15 | 1043-1050 | Chemical | denotes | KF17837 |
| T16 | 1092-1104 | Disease | denotes | parkinsonism |
bc5cdr-valid-gpt-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-7 | Chemical | denotes | KF17837 |
| T2 | 91-98 | Chemical | denotes | KF17837 |
| T3 | 178-185 | Chemical | denotes | KF17837 |
| T4 | 243-253 | Disease | denotes | cataleptic |
| T5 | 352-361 | Chemical | denotes | CGS 21680 |
| T6 | 407-414 | Chemical | denotes | KF17837 |
| T7 | 432-441 | Disease | denotes | catalepsy |
| T8 | 453-464 | Chemical | denotes | haloperidol |
| T9 | 487-496 | Chemical | denotes | reserpine |
| T10 | 638-645 | Chemical | denotes | KF17837 |
| T11 | 730-758 | Chemical | denotes | L-3,4-dihydroxyphenylalanine |
| T12 | 760-766 | Chemical | denotes | L-DOPA |
| T13 | 788-799 | Chemical | denotes | benserazide |
| T14 | 848-855 | Chemical | denotes | KF17837 |
| T15 | 1043-1050 | Chemical | denotes | KF17837 |
| T16 | 1092-1104 | Disease | denotes | parkinsonism |